Cedars-Sinai Cancer Center researchers confirmed in a large-scale nationwide survey that pancreatic cancer rates are growing and rising faster among younger women, than males of the same age. Their findings were published in the peer-reviewed journal Gastroenterology.
Study revealed the possible cause of pancreatic cancer. The findings hold implications for the targeted treatment of pancreatic ductal adenocarcinoma (PDAC), which accounts for the vast majority of all pancreatic tumors and is the fourth-leading cause of cancer-related deaths worldwide.
Researchers found and developed nanoparticles that simultaneously carry chemotherapy and a new immunotherapy. Chemotherapy is a pillar of cancer treatment, but residual cancer cells can persist and cause tumor relapse.